VR Logo

Unrated

DSP Healthcare Fund - Regular Plan


1 Lakh

Investment Grown to
₹ 1.18 Lakh

₹ 10000

Monthly SIP Grown to
₹ 1.39 Lakh

Analyst's Choice?

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in multi cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends paid by the mutual fund scheme are taxed at the rate of 10% (effectively 11.648%, including surcharge and cess). This is known as Dividend Distribution Tax (DDT). Though the investor does not pay this tax directly, it is deducted from the dividend income before passing on to the investor.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Fund 8.66 -0.13 1.70 9.41 14.51 17.37 18.41 -- -- -- --
S&P BSE Healthcare TRI 6.31 -0.24 1.93 6.41 9.98 10.63 5.33 -- -- -- --
Equity: Sectoral-Pharma 5.64 0.01 1.54 6.08 10.48 12.47 10.98 -- -- -- --
Rank within category 1 6 4 1 1 1 1 -- -- -- --
Number of funds in category 9 9 9 9 9 9 7 4 3 3 3

As on 28-Jan-2020

Best & Worst Performance

Best (Period) Worst (Period)
Week 3.87 (11-Oct-2019 - 18-Oct-2019) -3.92 (06-May-2019 - 13-May-2019)
Month 10.31 (07-Oct-2019 - 07-Nov-2019) -5.20 (12-Apr-2019 - 13-May-2019)
Quarter 14.46 (23-Oct-2019 - 22-Jan-2020) -7.37 (20-Mar-2019 - 19-Jun-2019)
Year 15.14 (24-Jan-2019 - 24-Jan-2020) 5.48 (20-Dec-2018 - 20-Dec-2019)

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Fund -- -- -- -- -- --
S&P BSE Healthcare TRI* -0.99 17.18 -0.39 -0.67 -- --
Equity: Sectoral-Pharma* 1.99 15.21 -0.24 -0.38 0.84 1.92
Rank within category -- -- -- -- -- --
Number of funds in category -- -- -- -- -- --

The Risk Measures have been calculated using calendar month returns for the last three years.

As on

* As on 31-Dec-2019

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 20
Top 10 Stocks (%) 62.90
Top 5 Stocks (%) 39.90
Top 3 Sectors (%) 97.37
Portfolio P/B Ratio 2.72
Portfolio P/E Ratio 24.78

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 15,921 23,393
Giant (%) 2.90 2.31
Large (%) 28.84 34.91
Mid (%) 42.17 51.37
Small (%) 26.10 13.21
Tiny (%) -- --

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
up Dr. Reddy's Lab Healthcare 31.16 10.41 5.33 10.41
down Ipca Laboratories Healthcare 26.28 11.48 6.13 9.63
up JB Chemicals & Pharma Healthcare 15.91 6.94 4.01 6.94
equal Divi's Laboratories Healthcare 40.08 7.09 3.98 6.80
down Sun Pharmaceutical Inds. Healthcare 25.09 14.33 6.12 6.12
equal Apollo Hospitals Healthcare 70.01 5.97 3.97 5.85
equal Indoco Remedies Healthcare 67.36 5.37 3.82 5.37
equal Jubilant Life Sciences Healthcare 16.01 4.15 2.48 4.15
equal Max India Financial -- 4.49 2.18 3.86
equal Syngene International Healthcare 31.87 3.77 1.97 3.77
equal Procter & Gamble Health Healthcare 54.87 3.86 0.00 3.55
up Torrent Pharmaceuticals Healthcare 57.91 3.46 2.46 3.46
equal Abbott India Healthcare 51.13 3.39 0.00 3.39
equal Alembic Pharmaceuticals Healthcare 16.35 3.56 2.76 3.37
equal Abiomed Inc Healthcare -- 3.18
equal Alkem Laboratories Healthcare 30.00 5.53 2.84 2.86
equal Unichem Laboratories Healthcare -- 4.31 2.86 2.86
equal Aarti Drugs Healthcare 13.61 3.16 2.45 2.83
equal Abbott Laboratories Healthcare -- 2.82
equal Ajanta Pharma Healthcare 26.21 3.16 2.54 2.65
equal Dr. Lal Pathlabs Healthcare 63.46 2.06 1.27 1.93
equal ICICI Lombard General Insurance Financial 53.38 2.17 1.52 1.57

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-Dec-2019

Fund Manager

— Aditya Khemka since 12-Nov-2018

Education: Mr. Khemka has done B.com, MSc in Finance & MBA

Experience: Prior to joining DSP Mutual Fund, he has worked with Ambit Capital Private Limited, Antique Stock Broking and Nomura Structured Financial Services.

— Vinit Sambre since 12-Nov-2018

Education: Mr. Sambre is a B.Com and FCA.

Experience: Prior to joining DSP he was associated with DSP Merrill Lynch Ltd.(Nov 2005 to Jun 2007), IL & FS Investsmart Ltd. (Dec 2002 to Oct 2005), Unit Trust of India Investment Advisory Services Ltd.(Jun 2000 to Dec 2002), Kisan Ratilal Choksey Shares and Securities Pvt. Ltd. (March 1999 to May 2000) and Credit Rating Information Service of India Ltd.(Apr 1998 to Feb 1999).

Interviews:

Funds Managed:


-0.13%

Change from previous, NAV as on 28-Jan-2020

Growth: ₹ 11.8400

Dividend: ₹ 11.8400


Investment Strategy

The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.

Investment Details

Minimum Investment (₹) 500
Minimum Addl Investment (₹) 500
Minimum SIP Investment (₹) 500
Minimum No of Cheques 12
Minimum Withdrawal (₹) 500
Minimum Balance (₹) 500
Exit Load 1% for redemption within 365 days

Basic Details

Fund House: DSP Mutual Fund
Launch Date: 30-Nov-2018
Return Since Launch: 15.65%
Benchmark: S&P BSE Healthcare TRI
Riskometer: High
Type: Open-ended
Assets: ₹ 243 Cr (As on 31-Dec-2019)
Expense: 2.37% (As on 31-Dec-2019)
Risk Grade: --
Return Grade: --
Turnover: 18.00%

Contact Information

AMC: DSP Investment Managers Pvt. Ltd.

Address: NATRAJ, Office No. 302-3rd Floor-Plot No. 194, MV Road Junction Western Express Highway, Andheri East Mumbai - 400069

Phone: 022-66178000

Fax: 022-56578181

Website: https://www.dspim.com/

Registrar & Transfer Agent: Computer Age Management Services Ltd.

Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai, Chennai - 600002

Phone: 1800-3010-6767 / 1800-419-7676

Fax: 044-30407101

Email: [email protected]

Website: www.camsonline.com

Upcoming Video

Investors' Hangout

How worrisome is the slowdown

dateFriday, 31-Jan-2020
time12:30 PM - 01:00 PM